Brief: Indaptus Therapeutics Presents Data Demonstrating Preclinical Efficacy Of Decoy, Its Bacteria-Based Immunotherapy Platform Technology, At The American Association For Cancer Research Conference 2023

Indaptus Therapeutics

19/04/2023 13:47

April 19 (Reuters) - Indaptus Therapeutics Inc  INDP.O :
    * INDAPTUS THERAPEUTICS PRESENTS DATA DEMONSTRATING
PRECLINICAL
EFFICACY OF DECOY, ITS BACTERIA-BASED IMMUNOTHERAPY PLATFORM
TECHNOLOGY, AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH
CONFERENCE 2023

Source text for Eikon:  ID:nGNX10pvqg 
Further company coverage:  INDP.O